[/tdc_zone]
LATEST ARTICLES
Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment...
Sage Therapeutics, Inc. (Nasdaq:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of...
Vaccinex CEO, Dr. Maurice Zauderer, Presented New and Promising Phase 2...
Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology Company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, a potent...
uniQure Announces Completion of Additional Patient Procedures Following Positive Recommendation from...
~ No Significant Safety Concerns Observed Across a Total of 14 Completed Procedures ~
~ Full Study Enrollment Expected to be Completed by Mid-2022 ~
LEXINGTON,...
UNIVERSITY
A NEW INTERNATIONAL CONSORTIUM TO PROMOTE STEM CELL-BASED THERAPY FOR HUNTINGTON’S...
The Stem Cells for Huntington’s Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on...
New therapeutic target for Huntington’s treatment
Huntington’s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations. The...
Optogenetic stimulation improves alterations in movement and behaviour of experimental models...
Huntington’s disease is an hereditary neurodegenerative disease featured by alterations in movement, cognitive deficiency and psychiatric disorders resulting from the degeneration of neurons in...
World first study reveals altered gut bacteria in Huntington’s Disease which...
The first clinical study of the gut microbiome in Huntington’s disease (HD) has found evidence of gut dysbiosis (altered bacteria in the gastrointestinal tract) in people...
HDBUZZ
Huntington’s disease therapeutics conference 2021 – Day 3
Catch up on all of the latest updates from day 3 of the 2021 CHDI Huntington’s disease therapeutics conference #HDTC2021
We are back for the...
Huntington’s disease therapeutics conference 2021 – Day 2
By Dr Rachel Harding, Dr Leora Fox, Dr Jeff Carroll, and Professor Ed Wild April 28, 2021 Edited by Dr Rachel Harding
Catch up on all of the latest updates from day...
ARTICLES
IONIS-HTTRx
